Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
6 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Resminostat plus sorafenib as second-line therapy of advanced hepatocellular carcinoma - The SHELTER study.
J Hepatol. 2016 Aug;65(2):280-8. doi: 10.1016/j.jhep.2016.02.043. Epub 2016 Mar 4.
J Hepatol. 2016.
PMID: 26952006
Clinical Trial.
Resminostat in patients with relapsed or refractory Hodgkin lymphoma: results of the phase II SAPHIRE study.
Walewski J, Paszkiewicz-Kozik E, Borsaru G, Hellmann A, Janikova A, Warszewska A, Mais A, Ammendola A, Herz T, Krauss B, Henning SW.
Walewski J, et al.
Leuk Lymphoma. 2019 Mar;60(3):675-684. doi: 10.1080/10428194.2018.1492122. Epub 2018 Aug 30.
Leuk Lymphoma. 2019.
PMID: 30160566
Clinical Trial.
Item in Clipboard
Domatinostat favors the immunotherapy response by modulating the tumor immune microenvironment (TIME).
Bretz AC, Parnitzke U, Kronthaler K, Dreker T, Bartz R, Hermann F, Ammendola A, Wulff T, Hamm S.
Bretz AC, et al.
J Immunother Cancer. 2019 Nov 8;7(1):294. doi: 10.1186/s40425-019-0745-3.
J Immunother Cancer. 2019.
PMID: 31703604
Free PMC article.
Item in Clipboard
Thienopyrimidines as β3-adrenoceptor agonists: hit-to-lead optimization.
Tasler S, Baumgartner R, Ammendola A, Schachtner J, Wieber T, Blisse M, Rath S, Zaja M, Klahn P, Quotschalla U, Ney P.
Tasler S, et al.
Bioorg Med Chem Lett. 2010 Oct 15;20(20):6108-15. doi: 10.1016/j.bmcl.2010.08.039. Epub 2010 Aug 12.
Bioorg Med Chem Lett. 2010.
PMID: 20833036
Item in Clipboard
A vHTS approach for the identification of beta-adrenoceptor ligands.
Tasler S, Baumgartner R, Aschenbrenner A, Ammendola A, Wolf K, Wieber T, Schachtner J, Blisse M, Quotschalla U, Ney P.
Tasler S, et al.
Bioorg Med Chem Lett. 2010 Jun 1;20(11):3399-404. doi: 10.1016/j.bmcl.2010.04.009. Epub 2010 Apr 9.
Bioorg Med Chem Lett. 2010.
PMID: 20434333
Item in Clipboard
The peptide-semicarbazone S-2209, a representative of a new class of proteasome inhibitors, induces apoptosis and cell growth arrest in multiple myeloma cells.
Baumann P, Müller K, Mandl-Weber S, Leban J, Doblhofer R, Ammendola A, Baumgartner R, Oduncu F, Schmidmaier R.
Baumann P, et al.
Br J Haematol. 2009 Mar;144(6):875-86. doi: 10.1111/j.1365-2141.2008.07570.x. Epub 2009 Jan 16.
Br J Haematol. 2009.
PMID: 19170678
Free article.
Item in Clipboard
Cite
Cite